CM Management, LLC
Source: SEC Form 13F · as of Mar 2026CM Management, LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $11.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$11.3M
BioSniper AIPage context preserved
Prepared research question
What matters most for Coherus Oncology, Inc. (CHRS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| CHRSCoherus Oncology, Inc. | 2,100,000 | $3.5M |
| OGNOrganon & Co. | 400,000 | $2.4M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 450,000 | $1.6M |
| XOMAXOMA Royalty Corporation | 40,000 | $1.3M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 1,000,000 | $800K |
| ASRTAssertio Holdings, Inc. | 35,000 | $667K |
| LTRNLantern Pharma Inc. | 250,000 | $343K |
| CGTXCOGNITION THERAPEUTICS INC | 400,000 | $304K |
| ELTXElicio Therapeutics, Inc. | 25,000 | $267K |
| BCDABioCardia, Inc. | 130,000 | $157K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.